Titel

Merkliste
1 Ergebnisse

Factors associated with recruitment success in the phase 2a..:

Jimenez-Rodriguez, Rosa M ; Martín-Gutiérrez, Guillermo ; Jiménez-Jorge, Silvia...
The REJUVENATE trial was supported by Innovative Medicines Initiative (IMI) Combatting Bacterial Resistance in Europe-Carbapenem-Resistance COMBACTE-CARE WP2B (G.A. 115620). Plan Nacional de I+D+i 2013‐2016 (Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases-REIPI) with the grants RD16/0016/009; RD16/0016/0008; RD16/0016/0001; RD16/0016/0015; RD16/0016/0004; RD16/0016/0012. The study was supported by the SCReNSpanish Clinical Research Network (PT13/0002/0010-PT17/0017/0012) from the National R+D+I Plan of the Institute of Health Carlos III (Ministerio de Ciencia, Innovación y Universidades).. , 2022

Link: https://hdl.handle.net/20.500.12412/4788

RT Journal
T1 <Title>Factors associated with recruitment success in the phase 2a study of aztreonam-avibactam development programme: A descriptive qualitative analysis among sites in Spain</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivloyola:oai:repositorio.uloyola.es:20.500.12412_4788&Exemplar=1&LAN=DE
				
A1 Jimenez-Rodriguez, Rosa M
A1 Martín-Gutiérrez, Guillermo
A1 Jiménez-Jorge, Silvia
A1 Rosso-Fernández, Clara M
A1 Tallón-Aguilar, Luis
A1 Roca-Oporto, Cristina
A1 Padillo, Javier
A1 Luckey, Alison
A1 Cano, Angela
A1 López-Ruiz, José
A1 Gómez-Zorrilla, Silvia
A1 Bonnín-Pascual, Jaime
A1 Boix-Palop, Lucía
A1 Montejo, José Miguel
A1 Torre-Cisneros, Julian
A1 Cisneros, José Miguel
YR 2022
K1 Clinical trials
K1 Diagnostic microbiology
K1 Microbiology
K1 Protocols & guidelines
K1 Statistics & research methods
JF The REJUVENATE trial was supported by Innovative Medicines Initiative (IMI) Combatting Bacterial Resistance in Europe-Carbapenem-Resistance COMBACTE-CARE WP2B (G.A. 115620). Plan Nacional de I+D+i 2013‐2016 (Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases-REIPI) with the grants RD16/0016/009; RD16/0016/0008; RD16/0016/0001; RD16/0016/0015; RD16/0016/0004; RD16/0016/0012. The study was supported by the SCReNSpanish Clinical Research Network (PT13/0002/0010-PT17/0017/0012) from the National R+D+I Plan of the Institute of Health Carlos III (Ministerio de Ciencia, Innovación y Universidades).
LK http://dx.doi.org/https://hdl.handle.net/20.500.12412/4788
DO https://hdl.handle.net/20.500.12412/4788
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)